Invention Grant
- Patent Title: Vitamin D3 lactone derivatives
- Patent Title (中): 维生素D3内酯衍生物
-
Application No.: US10543881Application Date: 2004-01-29
-
Publication No.: US09073885B2Publication Date: 2015-07-07
- Inventor: Kazuya Takenouchi , Miyuki Anzai , Hiroshi Saito , Kazuhisa Okada , Seiichi Ishizuka , Daishiro Miura , Hiroaki Takayama , Atsushi Kittaka , Nozomi Saito , Toshie Fujishima
- Applicant: Kazuya Takenouchi , Miyuki Anzai , Hiroshi Saito , Kazuhisa Okada , Seiichi Ishizuka , Daishiro Miura , Hiroaki Takayama , Atsushi Kittaka , Nozomi Saito , Toshie Fujishima
- Applicant Address: JP Tokyo
- Assignee: Teijin Pharma Limited
- Current Assignee: Teijin Pharma Limited
- Current Assignee Address: JP Tokyo
- Agency: Sughrue Mion, PLLC
- Priority: JP2003-021650 20030130; JP2003-339658 20030930
- International Application: PCT/JP2004/000815 WO 20040129
- International Announcement: WO2004/067525 WO 20040812
- Main IPC: A61K31/593
- IPC: A61K31/593 ; C07D307/58

Abstract:
A compound represented by the following Formula (1) that is effective for the treatment of Paget's disease of bone or hypercalcemia or a medically acceptable solvate thereof; [wherein R1 refers to hydrogen atom, C1-C6 alkyl group optionally substituted with hydrogen group or C1-C6 alkoxy group optionally substituted with hydroxyl group, R2a and R2b refer to hydrogen atom, C1-C10 alkyl group optionally substituted with hydroxyl group, C6-C10 aryl group optionally substituted with hydroxyl group or C7-C12 aralkyl group optionally substituted with a hydroxyl group, or are combined to represent ethylene group. However, a compound in which R1 is a hydrogen atom or a methyl group and R2a and R2b are hydrogen atoms is excluded].
Public/Granted literature
- US20060148768A1 Vitamin d3 lactone derivatives Public/Granted day:2006-07-06
Information query